Clinical trial NCT06401902: Diabetes and Risk of Ischemic Stroke.
Official title: Diabetes and Stroke: Does an Excess Risk of Hemodynamic Cerebral Ischemia Exist?
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Carotid Stenosis
Keywords: diabetes
ischemic stroke
cerebral hemorrhage
hypoperfusion
hyperperfusion
Lead sponsor: Institut Mutualiste Montsouris
Sponsor class: OTHER
First posted: 2024-05-07
Enrollment: 3739
Sex: ALL
Minimum age (years): 28
Maximum age (years): 97
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients with carotid stenosis requiring carotid surgery.

Brief summary: Diabetes in an independent risk factor for ischemic stroke, whose associated mortality rate is higher and sequelae more serious than for nondiabetics. Diabetes increases the risk of stroke or death after surgical carotid revascularization or endoluminal angioplasty. It is, with contralateral ICA occlusion, 1 of the 7 factors doubling the stroke risk after carotid endarterectomy. Diabetes also enhances the cerebral hemorrhage risk associated with carotid surgery, thrombectomy or thrombolysis revascularization of the cerebral arteries.

This study was undertaken to examine whether the hemodynamic cerebral ischemia (HCI) frequency, which increases stroke severity, is higher in diabetics than nondiabetics and, if diabetes carries an excess HCI risk, whether it is independent of contralateral ICA occlusion.

Detailed description: Embolic and hemodynamic mechanisms are the main causes underlying ischemic strokes of carotid origin. The hemodynamic cerebral ischemia (HCI) risk depends on the contribution of the contralateral internal carotid artery (ICA) and vertebral arteries via the circle of Willis, the ipsilateral external carotid artery via the ophthalmic artery and the leptomeningeal arteries. During carotid surgery, impaired collateral flow is associated with the need for shunt insertion.

When HCI is present, cerebral perfusion is initially maintained by vasodilation of precapillary arterioles and the increased extraction coefficient of oxygen. Secondarily, vascular reserve exhaustion by degradation of arterial lesions engenders a loss of cerebral autoregulation, ischemic penumbra and cerebral infarction.

Carotid revascularization with an incomplete circle of Willis enhances the postoperative ischemic stroke risk. The loss of cerebral autoregulation, attributable to HCI combined with ipsilateral carotid tight stenosis, heightens the risk of hyperperfusion and cerebral hemorrhage.

Carotid occlusion is the primary cause of HCI. Carotid occlusions and tight stenoses lead to loss of cerebral autoregulation and cerebrovascular reserve, and have been associated with a 4-fold-increased stroke risk.

Diabetes in an independent risk factor for ischemic stroke, whose associated mortality rate is higher and sequelae more serious than for nondiabetics. Diabetes increases the risk of stroke or death after surgical carotid revascularization or endoluminal angioplasty.It is, with contralateral ICA occlusion, 1 of the 7 factors doubling the stroke risk after carotid endarterectomy. Diabetes also enhances the cerebral hemorrhage risk associated with carotid surgery, thrombectomy or thrombolysis revascularization of the cerebral arteries.

This study was undertaken to examine whether the HCI frequency is higher in diabetics than nondiabetics and, if diabetes carries an excess HCI risk, whether it is independent of contralateral ICA occlusion.

Eligibility criteria: Inclusion Criteria:

* Patients with clamping test during carotid surgery.

Exclusion Criteria:

* Patients without clamping test during carotid surgery.

Primary outcomes:
measure: Intolerance to carotid clamping test
timeFrame: During clamping test
measure: Intolerance to carotid clamping test.
timeFrame: During clamping test
measure: Intolerance to carotid clamping test.
timeFrame: During clamping test
Secondary outcomes:
Other outcomes:
Locations:
city: Paris
country: France
facility: Mutualist Montsouris Institute
state: Ile De France
Study officials:
affiliation: Institut Mutualiste Montsouris
name: Christian Pr PETITJEAN
role: PRINCIPAL_INVESTIGATOR
References: